Skip to main content

01.12.2015 | Original Scientific Report

Prevention of Esophageal Stricture After Endoscopic Submucosal Dissection: A Systematic Review

verfasst von: Jiang-Ping Yu, Yong-Jun Liu, Ya-Li Tao, Rong-Wei Ruan, Zhao Cui, Shu-Wen Zhu, Wang Shi

Erschienen in: World Journal of Surgery | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Endoscopic submucosal dissection (ESD) is rapidly becoming a favored method for removing early esophageal cancer, but the residual defects can be complicated with strictures that require repeated endoscopic balloon dilatation. Measures for preventing the post-ESD strictures have been sought. We conducted a systematic review of recent studies to evaluate these methods.

Methods

We searched MEDLINE, Cochrane Central Register of Controlled Trials, Embase, and Google Scholar until November 30, 2014. Included studies were prospective and retrospective one- and two-arm studies. All studies had to include at least on preventive method for post-ESD stricture. Thirteen studies were included in the review.

Results

Among the studies that used corticosteroids to prevent post-ESD stricture, we found that (1) injection of triamcinolone acetonide into the esophageal lesion resulted in a substantial reduction in the rate of stricture, and (2) the use of oral prednisolone was associated with a significantly reduced rate of dilatation sessions and stricture. Studies of other preventative measures included more recently developed scaffold-based and cell-based tissue-engineering approaches which seem very promising but require additional rigorously controlled studies to test their effectiveness.

Conclusions

Until a safer and more effective method is developed, our review supports the use of corticosteroids, either through injection or oral route, together with endoscopic dilatation in prevention of post-ESD strictures.
Literatur
1.
Zurück zum Zitat Kobayashi S, Kanai N, Ohki T et al (2014) Prevention of esophageal strictures after endoscopic submucosal dissection. World J Gastroenterol 20(41):15098–15109PubMedCentralCrossRefPubMed Kobayashi S, Kanai N, Ohki T et al (2014) Prevention of esophageal strictures after endoscopic submucosal dissection. World J Gastroenterol 20(41):15098–15109PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Katada C, Muto M, Manabe T et al (2003) Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. Gastrointest Endosc 57(2):165–169CrossRefPubMed Katada C, Muto M, Manabe T et al (2003) Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. Gastrointest Endosc 57(2):165–169CrossRefPubMed
3.
Zurück zum Zitat Mizuta H, Nishimori I, Kuratani Y et al (2009) Predictive factors for esophageal stenosis after endoscopic submucosal dissection for superficial esophageal cancer. Dis Esophagus 22(7):626–631CrossRefPubMed Mizuta H, Nishimori I, Kuratani Y et al (2009) Predictive factors for esophageal stenosis after endoscopic submucosal dissection for superficial esophageal cancer. Dis Esophagus 22(7):626–631CrossRefPubMed
4.
Zurück zum Zitat Ono S, Fujishiro M, Niimi K et al (2009) Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 70(5):860–866CrossRefPubMed Ono S, Fujishiro M, Niimi K et al (2009) Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 70(5):860–866CrossRefPubMed
5.
Zurück zum Zitat Saito Y, Tanaka T, Andoh A et al (2008) Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci 53(2):330–333CrossRefPubMed Saito Y, Tanaka T, Andoh A et al (2008) Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci 53(2):330–333CrossRefPubMed
6.
Zurück zum Zitat Ono S, Fujishiro M, Niimi K et al (2009) Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms. Endoscopy 41(8):661–665CrossRefPubMed Ono S, Fujishiro M, Niimi K et al (2009) Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms. Endoscopy 41(8):661–665CrossRefPubMed
7.
Zurück zum Zitat Iizuka T, Kikuchi D, Yamada A et al (2015) Polyglycolic acid sheet application to prevent esophageal stricture after endoscopic submucosal dissection for esophageal squamous cell carcinoma. Endoscopy 47(4):341–344PubMed Iizuka T, Kikuchi D, Yamada A et al (2015) Polyglycolic acid sheet application to prevent esophageal stricture after endoscopic submucosal dissection for esophageal squamous cell carcinoma. Endoscopy 47(4):341–344PubMed
8.
Zurück zum Zitat Sakaguchi Y, Tsuji Y, Ono S et al (2015) Polyglycolic acid sheets with fibrin glue can prevent esophageal stricture after endoscopic submucosal dissection. Endoscopy 47(4):336–340PubMed Sakaguchi Y, Tsuji Y, Ono S et al (2015) Polyglycolic acid sheets with fibrin glue can prevent esophageal stricture after endoscopic submucosal dissection. Endoscopy 47(4):336–340PubMed
9.
Zurück zum Zitat Joo DC, Kim GH, do Park Y et al (2014) Long-term outcome after endoscopic submucosal dissection in patients with superficial esophageal squamous cell carcinoma: a single-center study. Gut Liver 8(6):612–618PubMedCentralCrossRefPubMed Joo DC, Kim GH, do Park Y et al (2014) Long-term outcome after endoscopic submucosal dissection in patients with superficial esophageal squamous cell carcinoma: a single-center study. Gut Liver 8(6):612–618PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Wen J, Lu Z, Yang Y et al (2014) Preventing stricture formation by covered esophageal stent placement after endoscopic submucosal dissection for early esophageal cancer. Dig Dis Sci 59(3):658–663CrossRefPubMed Wen J, Lu Z, Yang Y et al (2014) Preventing stricture formation by covered esophageal stent placement after endoscopic submucosal dissection for early esophageal cancer. Dig Dis Sci 59(3):658–663CrossRefPubMed
11.
Zurück zum Zitat Mori H, Rafiq K, Kobara H et al (2013) Steroid permeation into the artificial ulcer by combined steroid gel application and balloon dilatation: prevention of esophageal stricture. J Gastroenterol Hepatol 28(6):999–1003CrossRefPubMed Mori H, Rafiq K, Kobara H et al (2013) Steroid permeation into the artificial ulcer by combined steroid gel application and balloon dilatation: prevention of esophageal stricture. J Gastroenterol Hepatol 28(6):999–1003CrossRefPubMed
12.
Zurück zum Zitat Sato H, Inoue H, Kobayashi Y et al (2013) Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone. Gastrointest Endosc 78(2):250–257CrossRefPubMed Sato H, Inoue H, Kobayashi Y et al (2013) Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone. Gastrointest Endosc 78(2):250–257CrossRefPubMed
13.
Zurück zum Zitat Hanaoka N, Ishihara R, Takeuchi Y et al (2012) Intralesional steroid injection to prevent stricture after endoscopic submucosal dissection for esophageal cancer: a controlled prospective study. Endoscopy 44(11):1007–1011CrossRefPubMed Hanaoka N, Ishihara R, Takeuchi Y et al (2012) Intralesional steroid injection to prevent stricture after endoscopic submucosal dissection for esophageal cancer: a controlled prospective study. Endoscopy 44(11):1007–1011CrossRefPubMed
14.
Zurück zum Zitat Ohki T, Yamato M, Ota M, et al (2012) Prevention of esophageal stricture after endoscopic submucosal dissection using tissue-engineered cell sheets. Gastroenterology 143(3):582–588, e581–582 Ohki T, Yamato M, Ota M, et al (2012) Prevention of esophageal stricture after endoscopic submucosal dissection using tissue-engineered cell sheets. Gastroenterology 143(3):582–588, e581–582
15.
Zurück zum Zitat Uno K, Iijima K, Koike T et al (2012) A pilot study of scheduled endoscopic balloon dilation with oral agent tranilast to improve the efficacy of stricture dilation after endoscopic submucosal dissection of the esophagus. J Clin Gastroenterol 46(9):e76–82CrossRefPubMed Uno K, Iijima K, Koike T et al (2012) A pilot study of scheduled endoscopic balloon dilation with oral agent tranilast to improve the efficacy of stricture dilation after endoscopic submucosal dissection of the esophagus. J Clin Gastroenterol 46(9):e76–82CrossRefPubMed
16.
Zurück zum Zitat Yamashina T, Ishihara R, Uedo N et al (2012) Safety and curative ability of endoscopic submucosal dissection for superficial esophageal cancers at least 50 mm in diameter. Dig Endosc 24(4):220–225CrossRefPubMed Yamashina T, Ishihara R, Uedo N et al (2012) Safety and curative ability of endoscopic submucosal dissection for superficial esophageal cancers at least 50 mm in diameter. Dig Endosc 24(4):220–225CrossRefPubMed
17.
Zurück zum Zitat Hashimoto S, Kobayashi M, Takeuchi M et al (2011) The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc 74(6):1389–1393CrossRefPubMed Hashimoto S, Kobayashi M, Takeuchi M et al (2011) The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc 74(6):1389–1393CrossRefPubMed
18.
Zurück zum Zitat Isomoto H, Yamaguchi N, Nakayama T et al (2011) Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. BMC Gastroenterol 11:46PubMedCentralCrossRefPubMed Isomoto H, Yamaguchi N, Nakayama T et al (2011) Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. BMC Gastroenterol 11:46PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Yamaguchi N, Isomoto H, Nakayama T et al (2011) Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Gastrointest Endosc 73(6):1115–1121CrossRefPubMed Yamaguchi N, Isomoto H, Nakayama T et al (2011) Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Gastrointest Endosc 73(6):1115–1121CrossRefPubMed
20.
Zurück zum Zitat Yoda Y, Yano T, Kaneko K et al (2012) Endoscopic balloon dilatation for benign fibrotic strictures after curative nonsurgical treatment for esophageal cancer. Surg Endosc 26(10):2877–2883CrossRefPubMed Yoda Y, Yano T, Kaneko K et al (2012) Endoscopic balloon dilatation for benign fibrotic strictures after curative nonsurgical treatment for esophageal cancer. Surg Endosc 26(10):2877–2883CrossRefPubMed
21.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151(4):W65–94CrossRefPubMed Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151(4):W65–94CrossRefPubMed
23.
Zurück zum Zitat Kochhar R, Ray JD, Sriram PV et al (1999) Intralesional steroids augment the effects of endoscopic dilation in corrosive esophageal strictures. Gastrointest Endosc 49(4 Pt 1):509–513CrossRefPubMed Kochhar R, Ray JD, Sriram PV et al (1999) Intralesional steroids augment the effects of endoscopic dilation in corrosive esophageal strictures. Gastrointest Endosc 49(4 Pt 1):509–513CrossRefPubMed
24.
Zurück zum Zitat Isomoto H, Yamaguchi N, Minami H et al (2013) Management of complications associated with endoscopic submucosal dissection/endoscopic mucosal resection for esophageal cancer. Dig Endosc 25(Suppl 1):29–38CrossRefPubMed Isomoto H, Yamaguchi N, Minami H et al (2013) Management of complications associated with endoscopic submucosal dissection/endoscopic mucosal resection for esophageal cancer. Dig Endosc 25(Suppl 1):29–38CrossRefPubMed
25.
Zurück zum Zitat Lian JJ, Ma LL, Hu JW et al (2014) Endoscopic balloon dilatation for benign esophageal stricture after endoscopic submucosal dissection for early esophageal neoplasms. J Dig Dis 15(5):224–229CrossRefPubMed Lian JJ, Ma LL, Hu JW et al (2014) Endoscopic balloon dilatation for benign esophageal stricture after endoscopic submucosal dissection for early esophageal neoplasms. J Dig Dis 15(5):224–229CrossRefPubMed
26.
Zurück zum Zitat Ezoe Y, Muto M, Horimatsu T et al (2011) Efficacy of preventive endoscopic balloon dilation for esophageal stricture after endoscopic resection. J Clin Gastroenterol 45(3):222–227CrossRefPubMed Ezoe Y, Muto M, Horimatsu T et al (2011) Efficacy of preventive endoscopic balloon dilation for esophageal stricture after endoscopic resection. J Clin Gastroenterol 45(3):222–227CrossRefPubMed
27.
Zurück zum Zitat Wang C, Lu X, Chen P (2013) Clinical value of preventive balloon dilatation for esophageal stricture. Exp Ther Med 5(1):292–294PubMedCentralPubMed Wang C, Lu X, Chen P (2013) Clinical value of preventive balloon dilatation for esophageal stricture. Exp Ther Med 5(1):292–294PubMedCentralPubMed
28.
Zurück zum Zitat Matsumoto S, Miyatani H, Yoshida Y et al (2011) Cicatricial stenosis after endoscopic submucosal dissection of esophageal cancer effectively treated with a temporary self-expandable metal stent. Gastrointest Endosc 73(6):1309–1312CrossRefPubMed Matsumoto S, Miyatani H, Yoshida Y et al (2011) Cicatricial stenosis after endoscopic submucosal dissection of esophageal cancer effectively treated with a temporary self-expandable metal stent. Gastrointest Endosc 73(6):1309–1312CrossRefPubMed
29.
Zurück zum Zitat Barret M, Pratico CA, Camus M et al (2014) Amniotic membrane grafts for the prevention of esophageal stricture after circumferential endoscopic submucosal dissection. PLoS One 9(7):e100236PubMedCentralCrossRefPubMed Barret M, Pratico CA, Camus M et al (2014) Amniotic membrane grafts for the prevention of esophageal stricture after circumferential endoscopic submucosal dissection. PLoS One 9(7):e100236PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Hoppo T, Badylak SF, Jobe BA (2012) A novel esophageal-preserving approach to treat high-grade dysplasia and superficial adenocarcinoma in the presence of chronic gastroesophageal reflux disease. World J Surg 36(10):2390–2393. doi:10.1007/s00268-012-1698-6 CrossRefPubMed Hoppo T, Badylak SF, Jobe BA (2012) A novel esophageal-preserving approach to treat high-grade dysplasia and superficial adenocarcinoma in the presence of chronic gastroesophageal reflux disease. World J Surg 36(10):2390–2393. doi:10.​1007/​s00268-012-1698-6 CrossRefPubMed
31.
Zurück zum Zitat Nieponice A, Ciotola FF, Nachman F et al (2014) Patch esophagoplasty: esophageal reconstruction using biologic scaffolds. Ann Thorac Surg 97(1):283–288CrossRefPubMed Nieponice A, Ciotola FF, Nachman F et al (2014) Patch esophagoplasty: esophageal reconstruction using biologic scaffolds. Ann Thorac Surg 97(1):283–288CrossRefPubMed
32.
Zurück zum Zitat Machida H, Tominaga K, Minamino H et al (2012) Locoregional mitomycin C injection for esophageal stricture after endoscopic submucosal dissection. Endoscopy 44(6):622–625CrossRefPubMed Machida H, Tominaga K, Minamino H et al (2012) Locoregional mitomycin C injection for esophageal stricture after endoscopic submucosal dissection. Endoscopy 44(6):622–625CrossRefPubMed
33.
Zurück zum Zitat Mizutani T, Tadauchi A, Arinobe M et al (2010) Novel strategy for prevention of esophageal stricture after endoscopic surgery. Hepatogastroenterology 57(102–103):1150–1156PubMed Mizutani T, Tadauchi A, Arinobe M et al (2010) Novel strategy for prevention of esophageal stricture after endoscopic surgery. Hepatogastroenterology 57(102–103):1150–1156PubMed
Metadaten
Titel
Prevention of Esophageal Stricture After Endoscopic Submucosal Dissection: A Systematic Review
verfasst von
Jiang-Ping Yu
Yong-Jun Liu
Ya-Li Tao
Rong-Wei Ruan
Zhao Cui
Shu-Wen Zhu
Wang Shi
Publikationsdatum
01.12.2015
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 12/2015
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-015-3193-3

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.